Erratum: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation(RAAFT-2): A randomized trial (JAMA - Journal of the American Medical Association (2014) 311, 7 (692-699) DOI: 10.1001/jama.2014.467);Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2) a randomized trial

JAMA

Volumn 311, Issue 7, 2014, Pages 692-699

  Morillo, Carlos A ^a   Verma, Atul ^b   Connolly, Stuart J ^a   Kuck, Karl H ^c   Nair, Girish M ^d   Champagne, Jean ^e   Sterns, Laurence D ^f   Beresh, Heather ^a   Healey, Jeffrey S ^a   Natale, Andrea ^g  

^a MCMASTER UNIVERSITY   (Canada)

^b SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f Victoria Cardiac Arrhythmia Trials Inc   (Canada)

^g TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RHYTHM; HEART TAMPONADE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TACHYCARDIA; TREATMENT RESPONSE;

EID: 84894163826     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.1968     Document Type: Erratum

References (27)

1. Fuster V, Rydén LE, Cannom DS, et al European Heart Rhythm Association; Heart Rhythm Society; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48(4):854-906.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946-952. (Pubitemid 28446646)
3. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and heart failure and their joint influence on mortality. Circulation. 2003;107:2920-2925. (Pubitemid 36736633)
4. Dorian P, Paquette M, Newman D, et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J. 2002;143(6):984-990. (Pubitemid 34666888)
5. Singh SN, Tang XC, Singh BN, et al SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol. 2006;48(4):721-730. (Pubitemid 44175705)
6. Skanes AC, Healey JS, Cairns JA, et al Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol. 2012;28(2):125-136.
7. Calkins H, Brugada J, Packer DL, et al Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; Society of Thoracic Surgeons. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007;9(6):335-379.
8. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349-361.
9. Camm AJ, Lip GYH, De Caterina R, et al ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719-2747. doi:10.1093/eurheartj/ehs253.
10. Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study [published correction appeared in Circulation 2009;120:e83]. Circulation. 2008;118(24):2498-2505.
11. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340-2347. (Pubitemid 44856763)
12. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study. Eur Heart J. 2006;27(2):216-221. (Pubitemid 43069040)
13. Wilber DJ, Pappone C, Neuzil P, et al; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333-340.
14. Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(2):138-144.
15. Gjesdal K, Vist GE, Bugge E, et al. Curative ablation for atrial fibrillation: a systematic review. Scand Cardiovasc J. 2008;42(1):3-8. (Pubitemid 351462234)
16. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634-2640. (Pubitemid 40744248)
17. Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587-1595.
18. Tamborero D, Mont L, Berruezo A, et al. Circumferential pulmonary vein ablation: does use of a circular mapping catheter improve results? a prospective randomized study. Heart Rhythm. 2010;7(5):612-618.
19. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
20. EuroQol Group. EQ-5D Value Sets: Inventory, Comparative Eview and User Guide. Vol 2. Dordrecht, the Netherlands: Springer; 2007.
21. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stat. 1982;10:1100-1120.
22. Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005;112(3):307-313. (Pubitemid 41022070)
23. Pappone C, Vicedomini G, Augello G, et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ Arrhythm Electrophysiol. 2011;4(6):808-814.
24. Ha AC, Dorian P. Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation. J Interv Card Electrophysiol. 2013;36(2):177-184.
25. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32-38.
26. Dagres N, Hindricks G, Kottkamp H, et al. Complications of atrial fibrillation ablation in a high-volume center in 1000 procedures: still cause for concern? J Cardiovasc Electrophysiol. 2009;20(9):1014-1019.
27. Verma A, Champagne J, Sapp J, et al. Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation (AF) Pre- and Post-Radiofrequency AF Ablation (DISCERN AF): A Prospective, Multicenter Study. JAMA Intern Med. 2013;173:149-156.